If as a few posters have mentioned, Starpharma has invested $100m into spl7013.
Then why doesn't SPL invest single digit percentages of $100 000 000 into human clinical trials?
WHY, WHY, WHY ???????????????????
Could it be, that SPL is aware, spl7013 does not actually perform as well as the wonder antiviral SPL implies spl7013 to be?
Has the management team/BOD at SPL, mislead investors?
Interesting the elusive Steve Price interview that among other SPL items discusses the TGA was only posted on this forum days before, the Age/SMH artcle Australian COVID nasal spray not on shop shelves amid TGA dispute.
SPL Price at posting:
86.5¢ Sentiment: Sell Disclosure: Held
